Acute behavioural change in a young woman evolving towards cerebellar syndrome

G Naeije1, Q de Hemptinne, C Depondt

  • 1Department of Neurology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Insights

Antibodies against NMDA-glutamate receptors (A-NMDAR) can cause rare paraneoplastic neurological syndromes. This case highlights A-NMDAR encephalitis presenting with a unique cerebellar syndrome in a young woman.

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Background:

  • Paraneoplastic neurological syndromes are rare cancer manifestations.
  • Anti-NMDA receptor (A-NMDAR) encephalitis, often affecting young women, presents with psychiatric symptoms and altered consciousness.
  • This case explores a rare presentation and sequelae of A-NMDAR encephalitis.

Observation:

  • A young patient presented with acute delirium and a sub-comatose state.
  • Initial blood tests were normal, but cerebrospinal fluid showed lymphocytic pleocytosis.
  • Brain imaging (MRI, PET) was unremarkable, prompting investigation for paraneoplastic causes.

Findings:

  • A right ovarian teratoma and A-NMDAR antibodies were identified.
  • Surgical removal of the teratoma was performed.
  • The patient developed a cerebellar syndrome, a less common sequela.

Implications:

  • The cerebellar syndrome may result from A-NMDAR's disabling effect on NMDA-glutamate receptors shared by cortical and cerebellar neurons.
  • This case expands the understanding of A-NMDAR encephalitis presentations and its neurological manifestations.
  • Early diagnosis and treatment, including tumor removal, are crucial for managing A-NMDAR encephalitis.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...